Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 48101-48150 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05315674
Markers of COPD Exacerbations
N/A
Recruiting
150 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05627700
AVL200 IOL for Treatment of Cataract and Presbyopia
NA
Recruiting
60 participants
Started: Jul 25, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05268120
MRSA Decolonization in Complicated Carriage
NA
Recruiting
211 participants
Started: Jul 25, 2022 · Completed: May 1, 2028
1 condition
1 sponsor
1 location
NCT05100381
Effectiveness of Dry Needling in Patients With Chronic Nonspecific Low Back Pain
NA
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05484635
Mesh Removal Versus No Mesh Removal for Chronic Groin Pain After Inguinal Hernia Repair
NA
Recruiting
70 participants
Started: Jul 25, 2022 · Completed: Jul 1, 2028
2 conditions
1 sponsor
1 location
NCT05468255
The Impact of Removal of Exercise on Glycemic Control and Vascular Health in Older Active Adults
NA
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Apr 1, 2025
3 conditions
1 sponsor
1 location
NCT05340348
Patientheque in Patients With a Psychosis .
NA
Recruiting
250 participants
Started: Jul 25, 2022 · Completed: Jul 25, 2032
3 conditions
1 sponsor
1 location
NCT05636384
SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
NA
Recruiting
396 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2026
4 conditions
6 sponsors
6 locations
NCT05389904
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
NA
Recruiting
300 participants
Started: Jul 25, 2022 · Completed: Aug 31, 2026
1 condition
5 sponsors
1 location
NCT05442632
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
PHASE2
Recruiting
96 participants
Started: Jul 25, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05472987
Robotic Versus Open Ventral Hernia Repair
NA
Recruiting
200 participants
Started: Jul 25, 2022 · Completed: Aug 1, 2027
1 condition
1 sponsor
4 locations
NCT05422027
Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma
PHASE1/PHASE2
Recruiting
42 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
4 locations
NCT04567511
Hemlibra in Mild Hemophilia A
PHASE4
Recruiting
20 participants
Started: Jul 25, 2022 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT05407519
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
PHASE2
Recruiting
40 participants
Started: Jul 25, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT05436756
Chronic Post-leptospirosis Manifestations in Reunion
NA
Recruiting
198 participants
Started: Jul 25, 2022 · Completed: Jul 24, 2026
1 condition
1 sponsor
4 locations
NCT05425147
Correlation Between Perioperative Autonomic Function and Post-induction Hypotension in Elderly Patients
N/A
Recruiting
180 participants
Started: Jul 25, 2022 · Completed: Mar 1, 2025
1 condition
1 sponsor
1 location
NCT05331664
Dropless Pars Plana Vitrectomy Study
PHASE4
Recruiting
168 participants
Started: Jul 25, 2022 · Completed: Jan 30, 2027
1 condition
1 sponsor
1 location
NCT05442710
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy
PHASE2
Recruiting
142 participants
Started: Jul 24, 2022 · Completed: Jun 30, 2026
1 condition
3 sponsors
20 locations
NCT05492240
Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities
NA
Recruiting
2,880 participants
Started: Jul 24, 2022 · Completed: Jun 30, 2026
5 conditions
3 sponsors
2 locations
NCT06036225
PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.
NA
Recruiting
20 participants
Started: Jul 24, 2022 · Completed: Sep 27, 2024
1 condition
2 sponsors
1 location
NCT05497180
Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea
PHASE1
Recruiting
40 participants
Started: Jul 23, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05467813
Mirror Therapy Preceding Augmented Reality in Stroke Rehabilitation
NA
Recruiting
50 participants
Started: Jul 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT05286151
Network Connectivity and Temporal Processing in Adolescents Who Stutter
NA
Recruiting
500 participants
Started: Jul 23, 2022 · Completed: Jan 31, 2027
2 conditions
2 sponsors
1 location
NCT05501353
Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods
N/A
Recruiting
125 participants
Started: Jul 22, 2022 · Completed: Sep 1, 2027
1 condition
3 sponsors
1 location
NCT04968405
Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
NA
Recruiting
90 participants
Started: Jul 22, 2022 · Completed: Feb 28, 2026
3 conditions
1 sponsor
3 locations
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
PHASE4
Recruiting
1,656 participants
Started: Jul 22, 2022 · Completed: Aug 1, 2028
2 conditions
2 sponsors
26 locations
NCT05411198
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
PHASE3
Recruiting
65 participants
Started: Jul 22, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
25 locations
NCT05521789
Erector Spinae Block for Thoracic Surgery
PHASE4
Recruiting
70 participants
Started: Jul 22, 2022 · Completed: Jul 21, 2026
5 conditions
1 sponsor
1 location
NCT05254743
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
PHASE3
Recruiting
662 participants
Started: Jul 22, 2022 · Completed: Jan 31, 2028
4 conditions
1 sponsor
148 locations
NCT05189925
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
PHASE1
Recruiting
25 participants
Started: Jul 22, 2022 · Completed: Jul 1, 2026
2 conditions
1 sponsor
1 location
NCT04726059
Motor & Autonomic Concomitant Health Improvements With Neuromodulation & Exercise Training: An SCI RCT
NA
Recruiting
12 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2024
3 conditions
2 sponsors
1 location
NCT05476523
Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures
N/A
Recruiting
2,000 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05419375
Screening Study for Participants With Malignant Tumors
PHASE2
Recruiting
15,000 participants
Started: Jul 22, 2022 · Completed: Dec 22, 2032
1 condition
1 sponsor
162 locations
NCT05440617
Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy
N/A
Recruiting
100 participants
Started: Jul 22, 2022 · Completed: Sep 21, 2041
3 conditions
1 sponsor
1 location
NCT06706596
A Systemic Screening for TB Disease in High-risk Groups in Barcelona
N/A
Recruiting
3,000 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
2 conditions
9 sponsors
1 location
NCT05412823
Neurologic Function Post Intubation
N/A
Recruiting
1,000 participants
Started: Jul 22, 2022 · Completed: Aug 1, 2027
1 condition
1 sponsor
1 location
NCT07052539
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
N/A
Recruiting
60 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2026
3 conditions
1 sponsor
1 location
NCT05250180
Animal Assisted Therapy After Pediatric Brain Injury: Mediators and Moderators of Treatment Response.
NA
Recruiting
90 participants
Started: Jul 22, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT05763277
Ate-Bev Early Response Prediction Model in Advanced HCC
N/A
Recruiting
170 participants
Started: Jul 22, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT04404387
Lessening Organ Dysfunction With VITamin C in Septic ARDS
PHASE3
Recruiting
800 participants
Started: Jul 22, 2022 · Completed: Jul 31, 2024
2 conditions
1 sponsor
1 location
NCT05724264
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)
NA
Recruiting
1,000 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2029
1 condition
8 sponsors
3 locations
NCT05295368
Strategies for Kidney Outcomes Prevention and Evaluation - The SKOPE Study
NA
Recruiting
896 participants
Started: Jul 21, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05522192
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
PHASE1/PHASE2
Recruiting
70 participants
Started: Jul 21, 2022 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT05225714
Dermal Wound Closure Using Silkam®
N/A
Recruiting
164 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT05325645
Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
PHASE3
Recruiting
450 participants
Started: Jul 21, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05358431
Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers
NA
Recruiting
120 participants
Started: Jul 21, 2022 · Completed: Feb 21, 2026
1 condition
1 sponsor
1 location
NCT04886531
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
PHASE2
Recruiting
30 participants
Started: Jul 21, 2022 · Completed: Jan 31, 2026
4 conditions
3 sponsors
4 locations
NCT05067348
Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis
PHASE2
Recruiting
64 participants
Started: Jul 21, 2022 · Completed: Mar 30, 2026
1 condition
1 sponsor
6 locations
NCT05496686
Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma
PHASE1
Recruiting
16 participants
Started: Jul 21, 2022 · Completed: Feb 25, 2029
2 conditions
2 sponsors
1 location
NCT05371613
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
PHASE2/PHASE3
Recruiting
63 participants
Started: Jul 21, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
32 locations
Previous
1
More pages
960
961
962
963
964
965
966
More pages
1333
Next